S. . Ding, “Retracted ‘Serum amyloid P down-regulates CCL-1 expression, and inhibits Ras/MAPK signaling and development of breast cancer’”, Trop. J. Pharm Res, vol. 20, no. 10, p. 2235, Nov. 2021.